QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
QIAGEN and EQT Private Equity agreed on an all-cash voluntary public takeover offer for all outstanding QIAGEN shares at €46.50 per share. The price represents a 40.3% premium to the unaffected €33.15 XETRA close and values QIAGEN at approximately €10.8 billion in enterprise value (~$12.1 billion including ~$1.1 billion of net debt). QIAGEN's boards unanimously recommend acceptance. Closing is expected in mid-2027, subject to a 50%-plus-one minimum acceptance threshold, EGM approval of post-closing measures at 80% of votes cast, and merger control and foreign investment clearances.
Key figures
- Deal Value Usd
- $12.1 billion
- Offering Price
- €46.50
- Net debt
- approximately $1.1 billion
- Enterprise value
- approximately €10.8 billion
- Expected closing
- mid-2027
- Three month vwap
- €31.66
- Unaffected close
- €33.15
- Premium to 3m vwap
- 46.9%
- Interim dividend cap
- $0.47 per share
- Premium to unaffected
- 40.3%
- Egm approval threshold
- 80% of votes cast
- Minimum acceptance threshold
- 50% of outstanding share capital plus one share
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.